Avid Bioservices, Inc.
CDMO · NASDAQ
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Market Cap | $636 | $664 | $484 | $429 |
| - Cash | $33 | $33 | $38 | $31 |
| + Debt | $206 | $207 | $208 | $196 |
| Enterprise Value | $808 | $838 | $654 | $594 |
| Revenue | $33 | $40 | $43 | $34 |
| % Growth | -16.7% | -6.5% | 27.1% | – |
| Gross Profit | -$2 | $6 | $6 | $2 |
| % Margin | -6.1% | 14.2% | 12.8% | 7% |
| EBITDA | -$10 | -$0 | -$1 | -$3 |
| % Margin | -30.3% | -0.6% | -1.3% | -9.6% |
| Net Income | -$17 | -$6 | -$123 | -$6 |
| % Margin | -52% | -13.8% | -286.5% | -17.8% |
| EPS Diluted | -0.27 | -0.087 | -1.94 | -0.095 |
| % Growth | -210.3% | 95.5% | -1,944.3% | – |
| Operating Cash Flow | -$5 | -$4 | $1 | $4 |
| Capital Expenditures | $15 | -$1 | -$6 | -$4 |
| Free Cash Flow | $10 | -$5 | -$4 | -$1 |